Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Genmab

1,732.50 DKK

-0.46 %

Less than 1K followers

GMAB

NASDAQ Copenhagen

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Genmab

P/E

Median 2019-2025

EV/S

Median 2019-2024

EV/EBIT

Median 2019-2024

P/B

Median 2019-2025

 
2019202020212022202320242025
Share price (DKK)1,481.502,463.002,630.002,941.002,155.001,492.502,027.00
Shares65.065.065.066.066.166.264.2
Market cap96,248.6160,013.7170,863.2193,993.0142,390.698,784.4130,211.3
Enterprise value92,877.6144,253.7151,950.2172,266.0115,025.678,712.4-
EV/S17.314.317.911.87.03.7-
EV/EBITDA35.222.950.327.121.611.1-
EV/EBIT35.222.950.327.121.611.7-
P/E44.433.656.834.832.312.220.6
P/B6.858.377.707.074.502.693.50
P/S17.915.820.113.38.64.65.5
Dividend yield0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %
Equity ratio92.8 %90.4 %90.1 %90.6 %89.6 %80.1 %45.4 %
Gearing ratio1.3 %1.7 %1.9 %2.2 %2.4 %2.8 %92.8 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.